10x Genomics
TXG
TXG
266 hedge funds and large institutions have $3.19B invested in 10x Genomics in 2022 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 75 increasing their positions, 87 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
10% more call options, than puts
Call options by funds: $42.7M | Put options by funds: $38.9M
14% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 87
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
266
Holding in Top 10
5
Calls
$42.7M
Puts
$38.9M
Top Buyers
| 1 | +$40.4M | |
| 2 | +$36.4M | |
| 3 | +$34.2M | |
| 4 |
Man Group
London,
United Kingdom
|
+$19.8M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$18M |
Top Sellers
| 1 | -$18.6M | |
| 2 | -$15.5M | |
| 3 | -$14.4M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$12.3M |
| 5 |
BAMCO Inc
New York
|
-$10.8M |